- Home
- VSA vs APVO Comparison
VSA vs APVO Comparison
Compare VSA & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSA
- APVO
- Stock Information
- Founded
- VSA 2002
- APVO 2016
- Country
- VSA China
- APVO United States
- Employees
- VSA N/A
- APVO N/A
- Industry
- VSA
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- VSA
- APVO Health Care
- Exchange
- VSA NYSE
- APVO Nasdaq
- Market Cap
- VSA 7.8M
- APVO 4.1M
- IPO Year
- VSA N/A
- APVO N/A
- Fundamental
- Price
- VSA $0.79
- APVO $4.72
- Analyst Decision
- VSA
- APVO Strong Buy
- Analyst Count
- VSA 0
- APVO 1
- Target Price
- VSA N/A
- APVO $296.00
- AVG Volume (30 Days)
- VSA 225.7K
- APVO 376.0K
- Earning Date
- VSA 06-06-2025
- APVO 05-14-2025
- Dividend Yield
- VSA N/A
- APVO N/A
- EPS Growth
- VSA N/A
- APVO N/A
- EPS
- VSA N/A
- APVO N/A
- Revenue
- VSA $160,411,283.00
- APVO N/A
- Revenue This Year
- VSA N/A
- APVO N/A
- Revenue Next Year
- VSA N/A
- APVO N/A
- P/E Ratio
- VSA N/A
- APVO N/A
- Revenue Growth
- VSA N/A
- APVO N/A
- 52 Week Low
- VSA $0.18
- APVO $4.30
- 52 Week High
- VSA $2.00
- APVO $658.60
- Technical
- Relative Strength Index (RSI)
- VSA N/A
- APVO 25.64
- Support Level
- VSA N/A
- APVO $4.30
- Resistance Level
- VSA N/A
- APVO $5.18
- Average True Range (ATR)
- VSA 0.00
- APVO 1.21
- MACD
- VSA 0.00
- APVO 0.73
- Stochastic Oscillator
- VSA 0.00
- APVO 4.18
About VSA TCTM KIDS IT EDUCATION INC SPON ADS EA REP 5 ORD SHS(POST REV SPLT)
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has two operating segments: the IT Professional Education segment and the IT-focused Supplementary STEM Education Services segment. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.